Resultados de la búsqueda 291-300 of 3164 for anti-TNF drugs
... therapy, but this study will administer treatment in approximately 3 weeks. To achieve this shorter course, proton therapy is used. This study aims to ...
... therapy (but not surgery) and are in complete remission (no evidence of ... Radiation therapy is delivered using FDA-approved and commercially available methods.
... therapy; (2) if patient is already engaged in an ongoing cyclical systemic therapy, collection should be within three days prior to the end of the current ...
Participants in the treatment arm will take the supplement drug for 2 days. For all participants, an olive-sized sample of subcutaneous fat will be taken from ...
Semaglutide is a medicine, doctors can prescribe in some countries for the treatment of type 2 diabetes. Participants will get the study medicine in a pen.
Current treatment options include microsurgery, stereotactic radiosurgery and observation, using a “wait-and-scan” approach. The primary objective of this study ...
All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...
Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...
Giving lenalidomide and dexamethasone with daratumumab may work better in treating patients with smoldering myeloma. Testing the Addition of an Anti-cancer Drug ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?